LOCAL TREATMENT OF PERI- AND POSTMENOPAUSAL UROGENITAL DISORDERS

Great scientific and practical interest in the approach to therapy and prevention of isolated urogenital disorders caused by estrogen deficiency. Drug of choice for treating and preventing urogenital disorders is estrogenobuslovlennyh Ovestin containing estriol in sufficient therapeutic dosage. Afte...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Ovsyannikova, I. O. Makarov, E. I. Borovkova, I. A. Kulikov
Format: Article
Language:Russian
Published: IRBIS LLC 2016-09-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/259
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Great scientific and practical interest in the approach to therapy and prevention of isolated urogenital disorders caused by estrogen deficiency. Drug of choice for treating and preventing urogenital disorders is estrogenobuslovlennyh Ovestin containing estriol in sufficient therapeutic dosage. After the treatment course is shown the transition to supportive / preventive dose to prevent the resumption of symptoms. Climacteric syndrome with increasing life expectancy and the proportion of elderly in the population is a growing problem in women's health. Therapeutic and prophylactic approaches to urogenital disorders which were caused by estrogens deficit are present great interest. Ovestin containing estriol in sufficient therapeutic dosage is drug of choice for therapy and prevention of estrogen-related urogenital disorders. After the treatment course with Ovestin transition on supportive/ prophylactic dose is recommended for prevention of renewal of UGD symptoms.
ISSN:2313-7347
2500-3194